RU92014469A - MEANS FOR DETERMINING THE DEGREE OF ATTENUATION OF POLIOMYELITIS VIRUS - Google Patents

MEANS FOR DETERMINING THE DEGREE OF ATTENUATION OF POLIOMYELITIS VIRUS

Info

Publication number
RU92014469A
RU92014469A RU92014469/14A RU92014469A RU92014469A RU 92014469 A RU92014469 A RU 92014469A RU 92014469/14 A RU92014469/14 A RU 92014469/14A RU 92014469 A RU92014469 A RU 92014469A RU 92014469 A RU92014469 A RU 92014469A
Authority
RU
Russia
Prior art keywords
attenuation
determining
degree
poliomyelitis virus
poliomyelitis
Prior art date
Application number
RU92014469/14A
Other languages
Russian (ru)
Other versions
RU2064794C1 (en
Inventor
К.И. Спыну
П.К. Кинтя
Т.П. Грушко
В.П. Вуткарев
Е.И. Коцата
Original Assignee
Институт генетики АН Республики Молдова
Молдавский научно-исследовательский институт профилактической и клинической медицины
Filing date
Publication date
Application filed by Институт генетики АН Республики Молдова, Молдавский научно-исследовательский институт профилактической и клинической медицины filed Critical Институт генетики АН Республики Молдова
Priority to RU9292014469A priority Critical patent/RU2064794C1/en
Priority claimed from RU9292014469A external-priority patent/RU2064794C1/en
Publication of RU92014469A publication Critical patent/RU92014469A/en
Application granted granted Critical
Publication of RU2064794C1 publication Critical patent/RU2064794C1/en

Links

Claims (1)

Средство для определения степени аттенуации вируса полиомиелита относится к медицинской вирусологии, в частности к методам определения степени аттенуации вируса полиомиелита. Изобретение способствует расширению ассортимента маркеров для генетической характеристики полиовируса. Для этого предлагается использовать раствор томатозида - триазид - (25S) - 5α - 3b,22a,26 - триол - 26 - 0 - b - Д - глюкопиранозид-в конечной концентрации 0,01%.The means for determining the degree of attenuation of the poliomyelitis virus refers to medical virology, in particular, to methods for determining the degree of attenuation of the poliomyelitis virus. The invention contributes to the expansion of the range of markers for the genetic characterization of poliovirus. To do this, it is proposed to use a tomozide solution - triazide - (25S) - 5α - 3b, 22a, 26 - triol - 26 - 0 - b - D - glucopyranoside in a final concentration of 0.01%.
RU9292014469A 1992-12-24 1992-12-24 Agent for estimation of poliomyelitis virus attenuation degree RU2064794C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU9292014469A RU2064794C1 (en) 1992-12-24 1992-12-24 Agent for estimation of poliomyelitis virus attenuation degree

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU9292014469A RU2064794C1 (en) 1992-12-24 1992-12-24 Agent for estimation of poliomyelitis virus attenuation degree

Publications (2)

Publication Number Publication Date
RU92014469A true RU92014469A (en) 1995-04-20
RU2064794C1 RU2064794C1 (en) 1996-08-10

Family

ID=20134277

Family Applications (1)

Application Number Title Priority Date Filing Date
RU9292014469A RU2064794C1 (en) 1992-12-24 1992-12-24 Agent for estimation of poliomyelitis virus attenuation degree

Country Status (1)

Country Link
RU (1) RU2064794C1 (en)

Similar Documents

Publication Publication Date Title
ATE315938T1 (en) 4'-SUBSTITUTED NUCLEOSIDES FOR THE TREATMENT OF HEPATITIS C VIRUS-MEDIATED DISEASES
ATE241986T1 (en) USE OF QUINAZOLINE COMPOUNDS FOR THE TREATMENT OF POLYCYSTIC KIDNEY DISEASE
DE69114869D1 (en) Procedure for determining the profile of tires.
NO307968B1 (en) Pyrazolo- and pyrrolopyridines and pharmaceutical mixtures thereof
ATE510562T1 (en) ANTI-AILIM ANTIBODIES FOR THE TREATMENT OF CROHN'S
RU93058449A (en) HCV GENOMIC SEQUENCES FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES
DE69734483D1 (en) Polynucleotide vaccine, preferably for the treatment of respiratory disease in cattle
DE69012141D1 (en) LOCATION-SPECIFIC MODIFICATION OF THE CANDIDA TROPICALIS GENOMES.
DK0613696T3 (en) Medical-surgical tube with improved organ for fluid or gas treatment
DE68908616D1 (en) Process for the preparation of 1,1,1-trifluoro-2,2-dichloroethane.
DE69708121D1 (en) HALOGENID-CONTAINING INSULIN PREPARATIONS
NO20001869L (en) Procedure for the treatment of Alzheimer's disease
DE69737067D1 (en) VACCINE FOR THE TREATMENT OF MYCOSES
NO911065D0 (en) PROCEDURE FOR THE PREPARATION OF LIPOPEPTIDE DERIVATIVES.
DK1007040T3 (en) The use of phanquinone in the treatment of Alzheimer's disease
ATE252096T1 (en) PROLYLENDOPEPTIDASE INHIBITORS, THEIR PREPARATION AND THEIR PHARMACEUTICAL USE
ATE264309T1 (en) SUBSTITUTED CAPROLACTAM DERIVATIVES, PHARMACEUTICAL PREPARATIONS CONTAINING SAME AND THEIR USE FOR THE TREATMENT OF TUMORS
ATE261434T1 (en) TRIPTOLIDE DERIVATIVES SUITABLE FOR THE TREATMENT OF AUTOIMMUNE DISEASES
RU92014469A (en) MEANS FOR DETERMINING THE DEGREE OF ATTENUATION OF POLIOMYELITIS VIRUS
DK1294874T3 (en) CD154 variants and uses thereof
DE69615073D1 (en) Early detection of the risk of water condensation
DE59708511D1 (en) USE OF 7- (1-AMINOMETHYL-2-OXA-7-AZA-BICYCLO 3.3.0] OCT-7-YL) -CHINOLONCARBOXYLIC ACID AND -NAPHTHYRIDON-CARBONIC ACID DERIVATIVES FOR THE THERAPY OF HELICOBACTER-PYLOROXIDIZED INGENATIONALIZED INGENATIONAL ADHESIVES
ITMI913466A1 (en) PROCEDURE FOR THE PURIFICATION OF 1, 1, 1-TRIFLUORO-2-FLUOROETHANE AND 1, 1, 1-TRIFLUORO-2, 2-DICHLOROETHANE
DK1064014T3 (en) Drug for the prevention or treatment of papilloma virus-specific tumor
IT1278045B1 (en) USE OF 2-AMINOTETRALINE-6,7-SUBSTITUTED FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS SUITABLE FOR THE TREATMENT OF SHOCK, AND OF